期刊文献+

血管抑制因子METH1基因转染对兔耳瘢痕组织增生的影响 被引量:5

Effect of METH1 gene transfection on the proliferation of rabbit's ear scar
原文传递
导出
摘要 目的研究血管抑制因子METH1基因转染对兔耳瘢痕成纤维细胞增殖、胶原合成的影响。方法复制兔耳增生性瘢痕模型,用微循环显微镜检、瘢痕组织AgNOR染色、苦味酸-天狼星红染色等方法,观察基因重组血管抑制剂Ad-METH1对增生性瘢痕组织血管生成、成纤维细胞增殖、胶原分布的影响。结果Ad-METH1注射后30d瘢痕组织血管生成明显减少,成纤维细胞增殖减弱、Ⅰ/Ⅲ型胶原比明显降低。结论上皮化后早期血管抑制基因治疗可有效抑制增生性瘢痕的形成。 Objective To investigate the effect of METH1 gene transfection on fibroblast proliferation and Ⅰ ,Ⅲcollagen synthesis in rabbit ear scar. Methods The hypertrophic scar model on the rabbit ears was reproduced. 10 days after epithelization, Ad-METH1 was injected into the scar tissue. 30 days later, the effect of METH1 gene transfection on the angiogenesis, fibroblast proliferation and the ratio of collagen Ⅰ/Ⅲ in the scar tissue was detected by microcirculation microscope, AgNOR particle connt and collagen dyeing. Results 30 days after injection of Ad-METH1, angiogenesis, fibroblast proliferation and the ratio of collagen Ⅰ/Ⅲ in the scar tissue were obviously suppressed. Conclusion Early application of Ad-METH1 after epithelization can markedly inhibit the formation of the hypertrophic scar.
出处 《中华整形外科杂志》 CAS CSCD 北大核心 2008年第2期148-150,共3页 Chinese Journal of Plastic Surgery
基金 国家自然科学基金资助项目(30271346)
关键词 增生性瘢痕 新生血管化 生理性 基因治疗 Hypertophic scar Neovascularization, physiologic Gene therapy
  • 相关文献

参考文献12

  • 1王臻,郭树忠,张琳西,鲁开化.增生性瘢痕组织中血管形成的形态学[J].第四军医大学学报,2001,22(17):1612-1614. 被引量:23
  • 2岳毅刚,蒋常文,李佩英,周思.VEGF抗体靶向血管治疗增生性瘢痕的研究[J].中国实用美容整形外科杂志,2006,17(1):68-71. 被引量:13
  • 3李荟元,刘建波,夏炜,鲁开化,郭树忠.增生性瘢痕动物实验模型的建立与应用[J].中华整形外科杂志,2001,17(5):276-278. 被引量:101
  • 4张阳,鲁开化,郭树忠,宋革,杨国嵘,王臻,雷永红.人血管生成抑制分子的分子克隆与真核表达[J].中华整形外科杂志,2004,20(3):225-227. 被引量:10
  • 5Lee JP, Jalili RB, Trodget EE, et al. Antifibrogenic effects of liposome-encapsulatod IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res, 2005,25 : 627- 631.
  • 6Wu Y, Zhang Q, Ann DK, et al. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERKI/2 in keloid fibroblasts. Am J Physiol Cell Physiol, 2004,286: C905-912.
  • 7Clark JA, Leung KS, Cheng JC , et al. The hypertrophic scar and microcirculation properties. Burns, 1996,22:447-450.
  • 8Musgrave MA, Umraw N, Fish JS, et al. The effect of silicone gel sheets on perfusion of hypertrophic burn scars. J Burn Care Rehabil, 2002,23 : 208-214.
  • 9Yang GP, Lim IJ, Phan TT, et al. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen, 2003,11:411-418.
  • 10Jun JB, Kuechle M, Harlan JM, et al. Fibroblast and endothelial apoptoeis in systemic sclerosis. Curr Opin Rheumatol, 2003,15 : 756- 760.

二级参考文献25

  • 1周延冲.多肽生长因子基础与临床[M].北京:中国科学技术出版社,1992.253-267.
  • 2BISACCHI D,BENELLI R,VANZETTO C,et al.Anti-angiogenesis and angioprevention:mechanisms,problems and perspectives[J].Cancer Detect Prev,2003,27(3):229-238.
  • 3ZHU K Q,ENGRAV L H,ARMENDARIZ R,et al.Changes in VEGF and nitric oxide after deep dermal injury in the female,red Duroc pig-further similarities between female,Duroc scar and human hypertrophic scar[J].Burns,2005,31(1):5-10.
  • 4JONES M K,KAWANAKA H,BAATAR D,et al.Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1[J].Gastroenterology,2001,121(5):1040-1047.
  • 5GASTMAN B R,FUTRELL J W,MANDERS E K.Apoptosis and plastic surgery[J].Plast Reconstr Surg,2003,111(4):1481-1496.
  • 6FRANSON P J,LAPKA D V.Antivascular endothelial growth factor monoclonal antibody therapy:a promising paradigm in colorectal cancer[J].Clin J Oncol Nurs,2005,9(1):55-60.
  • 7Debus E S,Zentralbl Chir,2000年,125卷,suppl 1期,49页
  • 8Deng Z H,第四军医大学学报,1999年,19卷,1期,70页
  • 9Yan R L,第四军医大学学报,1999年,20卷,4期,291页
  • 10Majno G,Am J Pathol,1998年,153卷,4期,1035页

共引文献136

同被引文献93

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部